| Year |
Citation |
Score |
| 2022 |
Tittle JM, Schwark DG, Biddle W, Schmitt MA, Fisk JD. Impact of queuosine modification of endogenous tRNAs on sense codon reassignment. Frontiers in Molecular Biosciences. 9: 938114. PMID 36120552 DOI: 10.3389/fmolb.2022.938114 |
0.665 |
|
| 2022 |
Biddle W, Schwark DG, Schmitt MA, Fisk JD. Directed Evolution Pipeline for the Improvement of Orthogonal Translation Machinery for Genetic Code Expansion at Sense Codons. Frontiers in Chemistry. 10: 815788. PMID 35252113 DOI: 10.3389/fchem.2022.815788 |
0.678 |
|
| 2021 |
Schwark DG, Schmitt MA, Fisk JD. Directed Evolution of the Pyrrolysyl tRNA/aminoacyl tRNA Synthetase Pair for Rapid Evaluation of Sense Codon Reassignment Potential. International Journal of Molecular Sciences. 22. PMID 33477414 DOI: 10.3390/ijms22020895 |
0.682 |
|
| 2020 |
Schwark DG, Schmitt MA, Biddle W, Fisk JD. The Influence of Competing tRNA Abundance on Translation: Quantifying the Efficiency of Sense Codon Reassignment at Rarely Used Codons. Chembiochem : a European Journal of Chemical Biology. PMID 32203635 DOI: 10.1002/Cbic.202000052 |
0.689 |
|
| 2018 |
Schwark DG, Schmitt MA, Fisk JD. Dissecting the Contribution of Release Factor Interactions to Amber Stop Codon Reassignment Efficiencies of the Orthogonal Pair. Genes. 9. PMID 30424562 DOI: 10.3390/Genes9110546 |
0.684 |
|
| 2018 |
Schmitt MA, Biddle W, Fisk JD. Mapping the Plasticity of the E. coli Genetic Code with Orthogonal Pair Directed Sense Codon Reassignment. Biochemistry. PMID 29668270 DOI: 10.1021/Acs.Biochem.8B00177 |
0.695 |
|
| 2017 |
Zhao N, Spencer J, Schmitt MA, Fisk JD. Hyperthermostable binding molecules on phage: Assay components for point-of-care diagnostics for active tuberculosis infection. Analytical Biochemistry. PMID 28062210 DOI: 10.1016/J.Ab.2016.12.021 |
0.64 |
|
| 2016 |
Biddle W, Schmitt MA, Fisk JD. Modification of orthogonal tRNAs: unexpected consequences for sense codon reassignment. Nucleic Acids Research. 44: 10042-10050. PMID 27915288 DOI: 10.1093/Nar/Gkw948 |
0.685 |
|
| 2016 |
Smeal SW, Schmitt MA, Pereira RR, Prasad A, Fisk JD. Simulation of the M13 life cycle I: Assembly of a genetically-structured deterministic chemical kinetic simulation. Virology. PMID 27644585 DOI: 10.1016/J.Virol.2016.08.017 |
0.654 |
|
| 2016 |
Smeal SW, Schmitt MA, Pereira RR, Prasad A, Fisk JD. Simulation of the M13 life cycle II: Investigation of the control mechanisms of M13 infection and establishment of the carrier state. Virology. PMID 27569186 DOI: 10.1016/J.Virol.2016.08.015 |
0.65 |
|
| 2016 |
Zhao N, Schmitt MA, Fisk JD. Phage Display Selection of Tight Specific Binding Variants from a Hyperthermostable Sso7d Scaffold Protein Library. The Febs Journal. PMID 26835881 DOI: 10.1111/Febs.13674 |
0.663 |
|
| 2015 |
Biddle W, Schmitt MA, Fisk JD. Evaluating Sense Codon Reassignment with a Simple Fluorescence Screen. Biochemistry. PMID 26536053 DOI: 10.1021/Acs.Biochem.5B00870 |
0.695 |
|
| 2011 |
Freire F, Almeida AM, Fisk JD, Steinkruger JD, Gellman SH. Impact of strand length on the stability of parallel-β-sheet secondary structure. Angewandte Chemie (International Ed. in English). 50: 8735-8. PMID 21812082 DOI: 10.1002/Anie.201102986 |
0.747 |
|
| 2011 |
Van Deventer JA, Fisk JD, Tirrell DA. Homoisoleucine: a translationally active leucine surrogate of expanded hydrophobic surface area. Chembiochem : a European Journal of Chemical Biology. 12: 700-2. PMID 21404412 DOI: 10.1002/Cbic.201000731 |
0.366 |
|
| 2008 |
Freire F, Fisk JD, Peoples AJ, Ivancic M, Guzei IA, Gellman SH. Diacid linkers that promote parallel beta-sheet secondary structure in water. Journal of the American Chemical Society. 130: 7839-41. PMID 18507461 DOI: 10.1021/Ja802042C |
0.595 |
|
| 2006 |
Fisk JD, Schmitt MA, Gellman SH. Thermodynamic analysis of autonomous parallel beta-sheet formation in water. Journal of the American Chemical Society. 128: 7148-9. PMID 16734453 DOI: 10.1021/Ja060942P |
0.749 |
|
| 2004 |
Lai JR, Fisk JD, Weisblum B, Gellman SH. Hydrophobic core repacking in a coiled-coil dimer via phage display: insights into plasticity and specificity at a protein-protein interface. Journal of the American Chemical Society. 126: 10514-5. PMID 15327289 DOI: 10.1021/Ja047710F |
0.683 |
|
| 2003 |
Huck BR, Fisk JD, Guzei IA, Carlson HA, Gellman SH. Secondary structural preferences of 2,2-disubstituted pyrrolidine-4-carboxylic acid oligomers: beta-peptide foldamers that cannot form internal hydrogen bonds. Journal of the American Chemical Society. 125: 9035-7. PMID 15369358 DOI: 10.1021/Ja034561C |
0.771 |
|
| 2003 |
Syud FA, Stanger HE, Mortell HS, Espinosa JF, Fisk JD, Fry CG, Gellman SH. Influence of strand number on antiparallel beta-sheet stability in designed three- and four-stranded beta-sheets. Journal of Molecular Biology. 326: 553-68. PMID 12559922 DOI: 10.1016/S0022-2836(02)01304-9 |
0.783 |
|
| 2003 |
Syud FA, Stanger HE, Schenck Mortell H, Espinosa JF, Fisk JD, Fry CG, Gellman SH. Corrigendum to “Influence of Strand Number on Antiparallel β-Sheet Stability in Designed Three- and Four-Stranded β-Sheets” Journal of Molecular Biology. 328: 303. DOI: 10.1016/S0022-2836(03)00303-6 |
0.743 |
|
| 2002 |
Woll MG, Fisk JD, LePlae PR, Gellman SH. Stereoselective synthesis of 3-substituted 2-aminocyclopentanecarboxylic acid derivatives and their incorporation into short 12-helical beta-peptides that fold in water. Journal of the American Chemical Society. 124: 12447-52. PMID 12381185 DOI: 10.1021/Ja0258778 |
0.743 |
|
| 2002 |
LePlae PR, Fisk JD, Porter EA, Weisblum B, Gellman SH. Tolerance of acyclic residues in the beta-peptide 12-helix: access to diverse side-chain arrays for biological applications. Journal of the American Chemical Society. 124: 6820-1. PMID 12059191 DOI: 10.1021/Ja017869H |
0.757 |
|
| 2001 |
Langenhan JM, Fisk JD, Gellman SH. Evaluation of hydrogen bonding complementarity between a secondary sulfonamide and an alpha-amino acid residue. Organic Letters. 3: 2559-62. PMID 11483060 DOI: 10.1021/Ol016237X |
0.761 |
|
| 2001 |
Fisk JD, Gellman SH. A parallel beta-sheet model system that folds in water. Journal of the American Chemical Society. 123: 343-4. PMID 11456526 DOI: 10.1021/Ja002493D |
0.527 |
|
| 2000 |
Huck BR, Fisk JD, Gellman SH. Promotion of sheet formation in alpha-peptide strands by a beta-peptide reverse turn. Organic Letters. 2: 2607-10. PMID 10990408 DOI: 10.1021/Ol006120T |
0.792 |
|
| 2000 |
Fisk JD, Powell DR, Gellman SH. Control of hairpin formation via proline configuration in parallel β- sheet model systems Journal of the American Chemical Society. 122: 5443-5447. DOI: 10.1021/Ja9929483 |
0.558 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Kovacevic T, Skinner A, Fisk JD, Fishback V, Reed SM. A Semester-Long, Organic Chemistry Laboratory Structured around Unknown Analysis and Resynthesis as a Bridge to Guided-Inquiry Journal of Chemical Education. 97: 1633-1636. DOI: 10.1021/Acs.Jchemed.9B01037 |
0.257 |
|
| 2010 |
Beatty KE, Fisk JD, Smart BP, Lu YY, Szychowski J, Hangauer MJ, Baskin JM, Bertozzi CR, Tirrell DA. Live-cell imaging of cellular proteins by a strain-promoted azide-alkyne cycloaddition. Chembiochem : a European Journal of Chemical Biology. 11: 2092-5. PMID 20836119 DOI: 10.1002/Cbic.201000419 |
0.249 |
|
| 2011 |
Beatty KE, Szychowski J, Fisk JD, Tirrell DA. A BODIPY-cyclooctyne for protein imaging in live cells. Chembiochem : a European Journal of Chemical Biology. 12: 2137-9. PMID 21830285 DOI: 10.1002/Cbic.201100277 |
0.237 |
|
| 2000 |
Brown MG, Murray TJ, Sketris IS, Fisk JD, LeBlanc JC, Schwartz CE, Skedgel C. Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates. International Journal of Technology Assessment in Health Care. 16: 751-67. PMID 11028131 |
0.161 |
|
| 2021 |
Cash MK, Rockwood K, Fisk JD, Darvesh S. Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro. Neurobiology of Aging. 103: 31-41. PMID 33789210 DOI: 10.1016/j.neurobiolaging.2021.02.025 |
0.089 |
|
| 2014 |
Berrigan LI, Fisk JD, Walker LA, Wojtowicz M, Rees LM, Freedman MS, Marrie RA. Reliability of regression-based normative data for the oral symbol digit modalities test: an evaluation of demographic influences, construct validity, and impairment classification rates in multiple sclerosis samples. The Clinical Neuropsychologist. 28: 281-99. PMID 24438521 DOI: 10.1080/13854046.2013.871337 |
0.084 |
|
| 2019 |
Högg T, Zhao Y, Gustafson P, Petkau J, Fisk J, Marrie RA, Tremlett H. Adjusting for differential misclassification in matched case-control studies utilizing health administrative data. Statistics in Medicine. PMID 31115088 DOI: 10.1002/Sim.8203 |
0.081 |
|
| 2006 |
Jensen JS, Raab W, Fisk J, Hartz C, Saldana A, Harte C. Quality of polypropylene sockets for trans-tibial prostheses in low-income countries. Prosthetics and Orthotics International. 30: 45-59. PMID 16739781 DOI: 10.1080/03093640600568336 |
0.075 |
|
| 2021 |
Maxwell SP, Cash MK, Rockwood K, Fisk JD, Darvesh S. Clinical and neuropathological variability in the rare IVS10 + 14 tau mutation. Neurobiology of Aging. PMID 33612310 DOI: 10.1016/j.neurobiolaging.2021.01.004 |
0.075 |
|
| 2005 |
Fisk JD, Batten R, Jones G, O'Reilly JP, Shaw AM. pH dependence of the crystal violet adsorption isotherm at the silica-water interface. The Journal of Physical Chemistry. B. 109: 14475-80. PMID 16852824 DOI: 10.1021/jp051211z |
0.075 |
|
| 2013 |
Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, Fisk JD, Evans C, Béland SG, Kulaga S, Dykeman J, Wolfson C, Koch MW, Marrie RA. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. Bmc Neurology. 13: 128. PMID 24070256 DOI: 10.1186/1471-2377-13-128 |
0.073 |
|
| 1988 |
Fisk JD, Goodale MA. The effects of unilateral brain damage on visually guided reaching: hemispheric differences in the nature of the deficit. Experimental Brain Research. 72: 425-35. PMID 3224652 DOI: 10.1007/BF00250264 |
0.073 |
|
| 2020 |
Marrie RA, Whitehouse CE, Patel R, Figley CR, Kornelsen J, Bolton JM, Graff LA, Mazerolle EL, Marriott JJ, Bernstein CN, Fisk JD. Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample. Frontiers in Neurology. 11: 621010. PMID 33519702 DOI: 10.3389/fneur.2020.621010 |
0.071 |
|
| 1993 |
Fisk JD, Eastwood B, Sherwood G, Hanly JG. Patterns of cognitive impairment in patients with systemic lupus erythematosus. British Journal of Rheumatology. 32: 458-62. PMID 8508281 DOI: 10.1093/RHEUMATOLOGY/32.6.458 |
0.069 |
|
| 2006 |
Murphy PN, Wareing M, Fisk J. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study. Journal of Psychopharmacology (Oxford, England). 20: 447-55. PMID 16574719 DOI: 10.1177/0269881106063270 |
0.069 |
|
| 2014 |
Wojtowicz MA, Ishigami Y, Mazerolle EL, Fisk JD. Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis. Journal of Clinical and Experimental Neuropsychology. 36: 455-63. PMID 24742170 DOI: 10.1080/13803395.2014.903898 |
0.069 |
|
| 2010 |
Darvesh S, Leblanc AM, Macdonald IR, Reid GA, Bhan V, Macaulay RJ, Fisk JD. Butyrylcholinesterase activity in multiple sclerosis neuropathology. Chemico-Biological Interactions. 187: 425-31. PMID 20122907 DOI: 10.1016/j.cbi.2010.01.037 |
0.068 |
|
| 2013 |
Wojtowicz M, Omisade A, Fisk JD. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency. Journal of the International Neuropsychological Society : Jins. 19: 551-8. PMID 23425598 DOI: 10.1017/S1355617713000027 |
0.064 |
|
| 2019 |
Omisade A, O'Grady CB, Schmidt MH, Fisk JD. Visual and Auditory fMRI Paradigms for Presurgical Language Mapping: Convergent Validity and Relationship to Individual Variables. Neurology Research International. 2019: 6728120. PMID 31057966 DOI: 10.1155/2019/6728120 |
0.064 |
|
| 2012 |
Wojtowicz M, Berrigan LI, Fisk JD. Intra-individual Variability as a Measure of Information Processing Difficulties in Multiple Sclerosis. International Journal of Ms Care. 14: 77-83. PMID 24453737 DOI: 10.7224/1537-2073-14.2.77 |
0.063 |
|
| 2001 |
Snyder PJ, Cappelleri JC, Archibald CJ, Fisk JD. Improved detection of differential information-processing speed deficits between two disease-course types of multiple sclerosis. Neuropsychology. 15: 617-25. PMID 11761051 DOI: 10.1037/0894-4105.15.4.617 |
0.063 |
|
| 2001 |
Fisk JD, Archibald CJ. Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis. Journal of the International Neuropsychological Society : Jins. 7: 363-72. PMID 11311037 DOI: 10.1017/S1355617701733103 |
0.062 |
|
| 2006 |
Tuokko HA, Gabriel G, McDowell I, Fisk JD, Tierney MC, Crossley M, Simard M, Fisher N, Kristjansson B, Laforce R, Ska B, Snow G, Woodrow J, Bernier J, Tellier A, et al. Neuropsychological detection of cognitive impairment: Inter-rater agreement and factors affecting clinical decision-making Journal of the International Neuropsychological Society. 12: 72-79. PMID 16433946 DOI: 10.1017/S1355617706060103 |
0.062 |
|
| 2008 |
Hebb AL, Moore CS, Bhan V, Campbell T, Fisk JD, Robertson HA, Thorne M, Lacasse E, Holcik M, Gillard J, Crocker SJ, Robertson GS. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 577-94. PMID 18566024 DOI: 10.1177/1352458507087468 |
0.062 |
|
| 2022 |
Uddin MN, Figley TD, Kornelsen J, Mazerolle EL, Helmick CA, O'Grady CB, Pirzada S, Patel R, Carter S, Wong K, Essig MR, Graff LA, Bolton JM, Marriott JJ, Bernstein CN, ... Fisk JD, et al. The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines. Frontiers in Neuroimaging. 1: 970385. PMID 37555178 DOI: 10.3389/fnimg.2022.970385 |
0.061 |
|
| 1998 |
Fisk JD, Sadovnick AD, Cohen CA, Gauthier S, Dossetor J, Eberhart A, LeDuc L. Ethical guidelines of the Alzheimer Society of Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 25: 242-8. PMID 9706727 DOI: 10.1017/S0317167100034089 |
0.06 |
|
| 2019 |
Wijnands JMA, Zhu F, Kingwell E, Zhao Y, Evans C, Fisk JD, Marrie RA, Tremlett H. The prodrome in relapsing remitting and primary progressive multiple sclerosis. European Journal of Neurology. PMID 30714270 DOI: 10.1111/Ene.13925 |
0.06 |
|
| 2010 |
McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand'Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ. International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS). Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 946-51. PMID 20667058 DOI: 10.1111/j.1524-4733.2010.00767.x |
0.06 |
|
| 2007 |
O'Reilly JP, Fisk JD, Rooth M, Perkins E, Shaw AM. Non-linear plasmon response to protein binding at a nanostructured gold particle plasmon resonance surface. Physical Chemistry Chemical Physics : Pccp. 9: 344-5. PMID 17199149 DOI: 10.1039/b611337k |
0.06 |
|
| 2009 |
Veugelers PJ, Fisk JD, Brown MG, Stadnyk K, Sketris IS, Murray TJ, Bhan V. Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 1286-94. PMID 19965558 DOI: 10.1177/1352458509350307 |
0.06 |
|
| 2007 |
Fisk JD, Beattie BL, Donnelly M, Byszewski A, Molnar FJ. Disclosure of the diagnosis of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 404-10. PMID 19595961 DOI: 10.1016/j.jalz.2007.07.008 |
0.06 |
|
| 2017 |
Hamodat H, Cash MK, Fisk JD, Darvesh S. Cholinesterases in Normal and Alzheimer's Disease Primary Olfactory Gyrus. Neuropathology and Applied Neurobiology. PMID 28644906 DOI: 10.1111/nan.12423 |
0.06 |
|
| 2013 |
Mazerolle EL, Wojtowicz MA, Omisade A, Fisk JD. Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis. Neuroimage. Clinical. 2: 894-902. PMID 24179840 DOI: 10.1016/J.Nicl.2013.06.012 |
0.059 |
|
| 1997 |
Doble SE, Fisk JD, MacPherson KM, Fisher AG, Rockwood K. Measuring functional competence in older persons with Alzheimer's disease. International Psychogeriatrics / Ipa. 9: 25-38. PMID 9195276 DOI: 10.1017/S1041610297004171 |
0.058 |
|
| 2018 |
Scarapicchia V, Mazerolle EL, Fisk JD, Ritchie LJ, Gawryluk JR. Resting State BOLD Variability in Alzheimer's Disease: A Marker of Cognitive Decline or Cerebrovascular Status? Frontiers in Aging Neuroscience. 10: 39. PMID 29515434 DOI: 10.3389/Fnagi.2018.00039 |
0.058 |
|
| 2014 |
Ingles JL, Fisk JD, Fleetwood I, Burrell S, Darvesh S. Peripheral dysgraphia: dissociations of lowercase from uppercase letters and of print from cursive writing. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 27: 31-47. PMID 24674964 DOI: 10.1097/Wnn.0000000000000022 |
0.058 |
|
| 2014 |
Ploughman M, Beaulieu S, Harris C, Hogan S, Manning OJ, Alderdice PW, Fisk JD, Sadovnick AD, O'Connor P, Morrow SA, Metz LM, Smyth P, Mayo N, Marrie RA, Knox KB, et al. The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results. Bmj Open. 4: e005718. PMID 25011993 DOI: 10.1136/Bmjopen-2014-005718 |
0.058 |
|
| 2000 |
Archibald CJ, Fisk JD. Information processing efficiency in patients with multiple sclerosis. Journal of Clinical and Experimental Neuropsychology. 22: 686-701. PMID 11094403 DOI: 10.1076/1380-3395(200010)22:5;1-9;FT686 |
0.058 |
|
| 2012 |
Omisade A, Fisk JD, Klein RM, Schmidt M, Darvesh S, Bhan V. Information processing and magnetic resonance imaging indices of brain pathology in multiple sclerosis. International Journal of Ms Care. 14: 84-91. PMID 24453738 DOI: 10.7224/1537-2073-14.2.84 |
0.057 |
|
| 1993 |
Denburg SD, Denburg JA, Carbotte RM, Fisk JD, Hanly JG. Cognitive deficits in systemic lupus erythematosus. Rheumatic Diseases Clinics of North America. 19: 815-31. PMID 8265824 |
0.057 |
|
| 2018 |
Högg T, Wijnands JMA, Kingwell E, Zhu F, Lu X, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H. Mining healthcare data for markers of the multiple sclerosis prodrome. Multiple Sclerosis and Related Disorders. 25: 232-240. PMID 30121490 DOI: 10.1016/J.Msard.2018.08.007 |
0.057 |
|
| 1996 |
Troyer AK, Fisk JD, Archibald CJ, Ritvo PG, Murray TJ. Conceptual reasoning as a mediator of verbal recall in patients with multiple sclerosis. Journal of Clinical and Experimental Neuropsychology. 18: 211-9. PMID 8780956 DOI: 10.1080/01688639608408276 |
0.056 |
|
| 2015 |
Ploughman M, Manning OJ, Beaulieu S, Harris C, Hogan SH, Mayo N, Fisk JD, Sadovnick AD, O'Connor P, Morrow SA, Metz LM, Smyth P, Allderdice PW, Scott S, Marrie RA, et al. Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study. Bmc Health Services Research. 15: 161. PMID 25881078 DOI: 10.1186/S12913-015-0835-Y |
0.055 |
|
| 2002 |
Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, Foley F, LaRocca NG, Vowels L, Weinstein A, DeLuca J, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. The Clinical Neuropsychologist. 16: 381-97. PMID 12607150 DOI: 10.1076/Clin.16.3.381.13859 |
0.055 |
|
| 2023 |
Marrie RA, Fisk JD, Fitzgerald K, Kowalec K, Maxwell C, Rotstein D, Salter A, Tremlett H. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances. Frontiers in Immunology. 14: 1197195. PMID 37325663 DOI: 10.3389/fimmu.2023.1197195 |
0.055 |
|
| 2013 |
Ishigami Y, Fisk JD, Wojtowicz M, Klein RM. Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): stability, isolability, robustness, and reliability. Journal of Neuroscience Methods. 216: 1-9. PMID 23473799 DOI: 10.1016/j.jneumeth.2013.02.013 |
0.055 |
|
| 2022 |
Marrie RA, Patel R, Figley CR, Kornelsen J, Bolton JM, Graff LA, Mazerolle EL, Helmick C, Uddin MN, Figley TD, Marriott JJ, Bernstein CN, Fisk JD. Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure. Frontiers in Neurology. 13: 910014. PMID 35685743 DOI: 10.3389/fneur.2022.910014 |
0.054 |
|
| 2002 |
Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 11: 263-72. PMID 12074263 DOI: 10.1023/A:1015295106602 |
0.054 |
|
| 1994 |
Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 18: S79-83. PMID 8148458 |
0.054 |
|
| 2020 |
Ng HS, Zhu F, Kingwell E, Zhao Y, Yao S, Ekuma O, Svenson LW, Evans C, Fisk JD, Marrie RA, Tremlett H. Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting. Expert Review of Neurotherapeutics. PMID 33146570 DOI: 10.1080/14737175.2021.1847085 |
0.054 |
|
| 2024 |
Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JM, Evans C, Fisk JD, Marrie RA, Tremlett H. Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study. Lancet Regional Health. Americas. 29: 100667. PMID 38269206 DOI: 10.1016/j.lana.2023.100667 |
0.053 |
|
| 1989 |
Fisk JD, Goodale MA. The effects of instructions to subjects on the programming of visually directed reaching movements. Journal of Motor Behavior. 21: 5-19. PMID 15117669 DOI: 10.1080/00222895.1989.10735461 |
0.053 |
|
| 2005 |
Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 58-63. PMID 15607996 DOI: 10.1136/jnnp.2003.017897 |
0.053 |
|
| 2012 |
Andrew MK, Fisk JD, Rockwood K. Psychological well-being in relation to frailty: a frailty identity crisis? International Psychogeriatrics / Ipa. 24: 1347-53. PMID 22436131 DOI: 10.1017/S1041610212000269 |
0.052 |
|
| 2016 |
Litster B, Fiest KM, Patten SB, Fisk JD, Walker JR, Graff LA, Bolton JM, Sareen J, Marriott JJ, Berrigan LI, Bernstein CN, Zarychanski R, Singer A, Hitchon CA, Peschken CA, et al. Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review. International Journal of Ms Care. 18: 273-281. PMID 27999521 DOI: 10.7224/1537-2073.2016-004 |
0.051 |
|
| 2007 |
Manoharan I, Kuznetsova A, Fisk JD, Boopathy R, Lockridge O, Darvesh S. Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 939-45. PMID 17318303 DOI: 10.1007/S00702-007-0631-X |
0.05 |
|
| 1985 |
Fisk JD, Goodale MA. The organization of eye and limb movements during unrestricted reaching to targets in contralateral and ipsilateral visual space. Experimental Brain Research. 60: 159-78. PMID 4043274 DOI: 10.1007/BF00237028 |
0.05 |
|
| 1994 |
Doble SE, Fisk JD, Fisher AG, Ritvo PG, Murray TJ. Functional competence of community-dwelling persons with multiple sclerosis using the assessment of motor and process skills. Archives of Physical Medicine and Rehabilitation. 75: 843-51. PMID 8053789 DOI: 10.1016/0003-9993(94)90107-4 |
0.05 |
|
| 2023 |
Kornelsen J, McIver T, Uddin MN, Figley CR, Marrie RA, Patel R, Fisk JD, Carter S, Graff L, Mazerolle EL, Bernstein CN. Altered voxel-based and surface-based morphometry in inflammatory bowel disease. Brain Research Bulletin. 203: 110771. PMID 37797750 DOI: 10.1016/j.brainresbull.2023.110771 |
0.05 |
|
| 2012 |
Marrie RA, Yu BN, Leung S, Elliott L, Warren S, Wolfson C, Tremlett H, Blanchard J, Fisk JD. The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: A population-based study. Multiple Sclerosis and Related Disorders. 1: 162-7. PMID 25877264 DOI: 10.1016/j.msard.2012.06.001 |
0.049 |
|
| 1996 |
Sketris IS, Brown M, Murray TJ, Fisk JD, McLean K. Drug therapy in multiple sclerosis: a study of Nova Scotia senior citizens. Clinical Therapeutics. 18: 303-18; discussion 3. PMID 8733991 |
0.049 |
|
| 2012 |
Marrie RA, Yu BN, Leung S, Elliott L, Warren S, Wolfson C, Tremlett H, Fisk J, Blanchard J. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology. 39: 135-42. PMID 22889755 DOI: 10.1159/000339757 |
0.048 |
|
| 1984 |
St John R, Fisk JD, Timney B, Goodale MA. Eye movements of human albinos. American Journal of Optometry and Physiological Optics. 61: 377-85. PMID 6742098 DOI: 10.1097/00006324-198406000-00007 |
0.048 |
|
| 2022 |
Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JM, Evans C, Fisk JD, Marrie RA, Tremlett H. Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221078497. PMID 35232298 DOI: 10.1177/13524585221078497 |
0.048 |
|
| 1994 |
Hanly JG, Fisk JD, Eastwood B. Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus. Lupus. 3: 193-9. PMID 7951305 DOI: 10.1177/096120339400300311 |
0.047 |
|
| 2014 |
Koch MW, Murray TJ, Fisk J, Greenfield J, Bhan V, Jacobs P, Brown M, Metz LM. Hand dexterity and direct disease related cost in multiple sclerosis. Journal of the Neurological Sciences. 341: 51-4. PMID 24768310 DOI: 10.1016/J.Jns.2014.03.047 |
0.046 |
|
| 2023 |
Graf J, Ng HS, Zhu F, Zhao Y, Wijnands JMA, Evans C, Fisk JD, Marrie RA, Tremlett H. Multiple sclerosis disease-modifying drug use by immigrants: a real-world study. Scientific Reports. 13: 21235. PMID 38040796 DOI: 10.1038/s41598-023-46313-7 |
0.046 |
|
| 2021 |
Landrigan J, Bessenyei K, Leitner D, Yakovenko I, Fisk JD, Prentice JL. A systematic review of the effects of cannabis on cognition in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 57: 103338. PMID 35158449 DOI: 10.1016/j.msard.2021.103338 |
0.045 |
|
| 2011 |
Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study. Journal of Alzheimer's Disease : Jad. 26: 359-67. PMID 21971475 DOI: 10.3233/JAD-2011-0048 |
0.045 |
|
| 2020 |
Zhao Y, Wijnands JMA, Högg T, Kingwell E, Zhu F, Evans C, Fisk JD, Marrie RA, Tremlett H. Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health Data. Neuroepidemiology. 1-8. PMID 31940638 DOI: 10.1159/000505331 |
0.045 |
|
| 2023 |
Patel R, Marrie RA, Bernstein CN, Bolton JM, Graff LA, Marriott JJ, Figley CR, Kornelsen J, Mazerolle EL, Uddin MN, Fisk JD. Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease. Scientific Reports. 13: 4317. PMID 36922532 DOI: 10.1038/s41598-023-31160-3 |
0.045 |
|
| 2023 |
Carter SL, Patel R, Fisk JD, Figley CR, Marrie RA, Mazerolle EL, Uddin MN, Wong K, Graff LA, Bolton JM, Marriott JJ, Bernstein CN, Kornelsen J. Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed. Frontiers in Neurology. 14: 1250894. PMID 37928146 DOI: 10.3389/fneur.2023.1250894 |
0.045 |
|
| 2018 |
Mayo CD, Garcia-Barrera MA, Mazerolle EL, Ritchie LJ, Fisk JD, Gawryluk JR. Relationship Between DTI Metrics and Cognitive Function in Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 436. PMID 30687081 DOI: 10.3389/Fnagi.2018.00436 |
0.045 |
|
| 2014 |
Marrie RA, Fisk JD, Stadnyk KJ, Tremlett H, Wolfson C, Warren S, Bhan V, Yu BN. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia. Chronic Diseases and Injuries in Canada. 34: 145-53. PMID 24991777 |
0.045 |
|
| 2018 |
McKay KA, Marrie RA, Fisk JD, Patten SB, Tremlett H. Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study. Neuroepidemiology. 51: 1-10. PMID 29763935 DOI: 10.1159/000488799 |
0.045 |
|
| 2003 |
Tuokko H, Frerichs R, Graham J, Rockwood K, Kristjansson B, Fisk J, Bergman H, Kozma A, McDowell I. Five-year follow-up of cognitive impairment with no dementia. Archives of Neurology. 60: 577-82. PMID 12707072 DOI: 10.1001/Archneur.60.4.577 |
0.045 |
|
| 2021 |
Parks NE, Andreou P, Marrie RA, Fisk JD, Bhan V, Kirkland SA. Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 56: 103249. PMID 34517192 DOI: 10.1016/j.msard.2021.103249 |
0.044 |
|
| 2007 |
Jacova C, Kertesz A, Blair M, Fisk JD, Feldman HH. Neuropsychological testing and assessment for dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 299-317. PMID 19595951 DOI: 10.1016/J.Jalz.2007.07.011 |
0.044 |
|
| 2003 |
Ingles JL, Fisk JD, Merry HR, Rockwood K. Five-year outcomes for dementia defined solely by neuropsychological test performance. Neuroepidemiology. 22: 172-8. PMID 12711849 DOI: 10.1159/000069891 |
0.044 |
|
| 2016 |
Zhang T, Tremlett H, Leung S, Zhu F, Kingwell E, Fisk JD, Bhan V, Campbell TL, Stadnyk K, Yu BN, Marrie RA. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis. Neurology. PMID 26944268 DOI: 10.1212/WNL.0000000000002543 |
0.044 |
|
| 2007 |
Fisk JD, Beattie BL, Donnelly M. Ethical considerations for decision making for treatment and research participation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 411-7. PMID 19595962 DOI: 10.1016/j.jalz.2007.08.001 |
0.044 |
|
| 2010 |
Morris C, Condie D, Fisk J. ISPO Cerebral Palsy Consensus Conference Report (available free at www.ispoweb.org). Prosthetics and Orthotics International. 33: 401-2. PMID 19961299 DOI: 10.3109/03093640903311400 |
0.043 |
|
| 2013 |
Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, Tremlett H, Blanchard JF, Patten SB. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. Bmc Neurology. 13: 16. PMID 23388102 DOI: 10.1186/1471-2377-13-16 |
0.043 |
|
| 2013 |
Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology. 40: 85-92. PMID 23095571 DOI: 10.1159/000343188 |
0.043 |
|
| 2017 |
McKay KA, Evans C, Fisk JD, Patten SB, Fiest K, Marrie RA, Tremlett H. Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records. Neuroepidemiology. 48: 124-130. PMID 28683461 DOI: 10.1159/000477771 |
0.043 |
|
| 2011 |
Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C, Khan NM, Leslie RA, Robertson HA. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. Journal of Neurology. 258: 1254-60. PMID 21287185 DOI: 10.1007/S00415-011-5915-2 |
0.043 |
|
| 2015 |
Kingwell E, Zhu F, Marrie RA, Fisk JD, Wolfson C, Warren S, Profetto-McGrath J, Svenson LW, Jette N, Bhan V, Yu BN, Elliott L, Tremlett H. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010). Journal of Neurology. PMID 26205633 DOI: 10.1007/S00415-015-7842-0 |
0.043 |
|
| 2016 |
McKay KA, Tremlett H, Patten SB, Fisk JD, Evans C, Fiest K, Campbell T, Marrie RA. Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27357507 DOI: 10.1177/1352458516657440 |
0.042 |
|
| 1999 |
Doble SE, Fisk JD, Rockwood K. Assessing the ADL functioning of persons with Alzheimer's disease: comparison of family informants' ratings and performance-based assessment findings. International Psychogeriatrics / Ipa. 11: 399-409. PMID 10631585 DOI: 10.1017/S1041610299006018 |
0.042 |
|
| 2013 |
Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF. Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study. Multiple Sclerosis and Related Disorders. 2: 355-61. PMID 25877846 DOI: 10.1016/j.msard.2013.03.001 |
0.042 |
|
| 2020 |
Pirzada S, Uddin MN, Figley TD, Kornelsen J, Puig J, Marrie RA, Mazerolle EL, Fisk JD, Helmick CA, O'Grady CB, Patel R, Figley CR. Spatial normalization of multiple sclerosis brain MRI data depends on analysis method and software package. Magnetic Resonance Imaging. PMID 32007558 DOI: 10.1016/J.Mri.2020.01.016 |
0.042 |
|
| 2005 |
Fisk JD, Hayes NW, Barnett D, Farries M, Tasker KM, Shaw AM. Fibre optic implementation of evanescent wave cavity ring-down spectroscopy for chemical detection Proceedings of Spie - the International Society For Optical Engineering. 5990. DOI: 10.1117/12.634313 |
0.042 |
|
| 2003 |
Busche KD, Fisk JD, Murray TJ, Metz LM. Short term predictors of unemployment in multiple sclerosis patients. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 30: 137-42. PMID 12774953 |
0.041 |
|
| 2005 |
Fisk JD, Rockwood K. Outcomes of incident mild cognitive impairment in relation to case definition. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1175-7. PMID 16024904 DOI: 10.1136/jnnp.2004.053751 |
0.041 |
|
| 2007 |
Ingles JL, Fisk JD, Passmore M, Darvesh S. Progressive anomia without semantic or phonological impairment. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 43: 558-64. PMID 17624002 DOI: 10.1016/S0010-9452(08)70250-8 |
0.041 |
|
| 2010 |
Rendas-Baum R, Yang M, Cattelin F, Wallenstein GV, Fisk JD. A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 19: 1349-58. PMID 20617385 DOI: 10.1007/s11136-010-9704-7 |
0.041 |
|
| 2018 |
Marrie RA, Ekuma O, Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Tremlett H. Identifying optic neuritis and transverse myelitis using administrative data. Multiple Sclerosis and Related Disorders. 25: 258-264. PMID 30144696 DOI: 10.1016/J.Msard.2018.08.013 |
0.041 |
|
| 2007 |
Fisk JD, Rooth M, Shaw AM. Gold nanoparticle adsorption and aggregation kinetics at the silica-water interface Journal of Physical Chemistry C. 111: 2588-2594. DOI: 10.1021/jp063759r |
0.041 |
|
| 2017 |
Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott JJ, Bernstein CN. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Multiple Sclerosis and Related Disorders. 20: 9-15. PMID 29274564 DOI: 10.1016/J.Msard.2017.12.007 |
0.04 |
|
| 2016 |
Wijnands JM, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Marrie RA, Tremlett H. Infection-related health care utilization among people with and without multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458516681198. PMID 28273769 DOI: 10.1177/1352458516681198 |
0.04 |
|
| 2017 |
Marrie RA, Patten SB, Tremlett H, Wolfson C, Leung S, Fisk JD. Increased incidence and prevalence of psoriasis in multiple sclerosis. Multiple Sclerosis and Related Disorders. 13: 81-86. PMID 28427708 DOI: 10.1016/j.msard.2017.02.012 |
0.04 |
|
| 2019 |
Marrie RA, Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Ekuma O, Lu X, Evans C, Fisk JD, Tremlett H. Higher health care use before a clinically isolated syndrome with or without subsequent MS. Multiple Sclerosis and Related Disorders. 35: 42-49. PMID 31319354 DOI: 10.1016/J.Msard.2019.07.002 |
0.04 |
|
| 2018 |
Wijnands JM, Zhu F, Kingwell E, Zhao Y, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H. Five years before multiple sclerosis onset: Phenotyping the prodrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518783662. PMID 29979093 DOI: 10.1177/1352458518783662 |
0.04 |
|
| 2018 |
Wijnands JMA, Ekuma O, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, Tremlett H, Marrie RA. MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis. Multiple Sclerosis and Related Disorders. 28: 138-144. PMID 30594814 DOI: 10.1016/J.Msard.2018.12.030 |
0.04 |
|
| 2018 |
Wijnands JMA, Zhu F, Kingwell E, Fisk JD, Evans C, Marrie RA, Zhao Y, Tremlett H. Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29602795 DOI: 10.1136/Jnnp-2017-317493 |
0.039 |
|
| 2022 |
Ng HS, Zhu F, Kingwell E, Yao S, Ekuma O, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H. Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35701187 DOI: 10.1212/NXI.0000000000200005 |
0.039 |
|
| 2014 |
Wojtowicz M, Mazerolle EL, Bhan V, Fisk JD. Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1453-63. PMID 24619937 DOI: 10.1177/1352458514524997 |
0.039 |
|
| 1983 |
Carter BL, Bankoff MS, Fisk JD. Computed tomographic detection of sinusitis responsible for intracranial and extracranial infections. Radiology. 147: 739-42. PMID 6844609 DOI: 10.1148/radiology.147.3.6844609 |
0.039 |
|
| 2018 |
Enns MW, Bernstein CN, Kroeker K, Graff L, Walker JR, Lix LM, Hitchon CA, El-Gabalawy R, Fisk JD, Marrie RA. The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases. Plos One. 13: e0198975. PMID 29879231 DOI: 10.1371/Journal.Pone.0198975 |
0.038 |
|
| 2023 |
Marrie RA, Bernstein CN, Dolovich C, Bolton JM, Graff LA, Hitchon CA, Lix LM, Marriott JJ, Fisk JD. Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231190771. PMID 37537962 DOI: 10.1177/13524585231190771 |
0.038 |
|
| 1993 |
Hanly JG, Walsh NM, Fisk JD, Eastwood B, Hong C, Sherwood G, Jones JV, Jones E, Elkon K. Cognitive impairment and autoantibodies in systemic lupus erythematosus. British Journal of Rheumatology. 32: 291-6. PMID 8461922 DOI: 10.1093/RHEUMATOLOGY/32.4.291 |
0.038 |
|
| 2009 |
Tappenden P, McCabe C, Chilcott J, Simpson E, Nixon R, Madan J, Fisk JD, Brown M. Cost-effectiveness of disease-modifying therapies in the management of multiple sclerosis for the Medicare population. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 657-65. PMID 19508662 DOI: 10.1111/j.1524-4733.2008.00485.x |
0.037 |
|
| 2007 |
Rockwood K, Howlett S, Fisk J, Darvesh S, Tuokko H, Hogan DB, Wolfson C, McDowell I. Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status. Neuroepidemiology. 29: 201-7. PMID 18043005 DOI: 10.1159/000111583 |
0.037 |
|
| 2023 |
Patel R, Marrie RA, Bernstein CN, Bolton JM, Graff LA, Marriott JJ, Figley CR, Kornelsen J, Mazerolle EL, Helmick C, Uddin MN, Fisk JD. Vascular Disease Is Associated With Differences in Brain Structure and Lower Cognitive Functioning in Inflammatory Bowel Disease: A Cross-Sectional Study. Inflammatory Bowel Diseases. PMID 37740523 DOI: 10.1093/ibd/izad204 |
0.037 |
|
| 2024 |
Ng HS, Zhu F, Zhao Y, Yao S, Lu X, Ekuma O, Evans C, Fisk JD, Marrie RA, Tremlett H. Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis. Neurology. 102: e208006. PMID 38181306 DOI: 10.1212/WNL.0000000000208006 |
0.037 |
|
| 2018 |
Gasim M, Bernstein CN, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Marriott JJ, Fisk JD, Marrie RA. Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review. Multiple Sclerosis and Related Disorders. 26: 124-156. PMID 30248593 DOI: 10.1016/J.Msard.2018.09.008 |
0.037 |
|
| 2017 |
Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Högg T, Stadnyk K, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study. The Lancet. Neurology. PMID 28434855 DOI: 10.1016/S1474-4422(17)30076-5 |
0.037 |
|
| 2021 |
Ng HS, Graf J, Zhu F, Kingwell E, Aktas O, Albrecht P, Hartung HP, Meuth SG, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H. Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population. Frontiers in Immunology. 12: 794075. PMID 35095869 DOI: 10.3389/fimmu.2021.794075 |
0.036 |
|
| 2016 |
Marrie RA, Fisk J, Tremlett H, Wolfson C, Warren S, Blanchard J, Patten SB. Differing trends in the incidence of vascular comorbidity in MS and the general population. Neurology. Clinical Practice. 6: 120-128. PMID 27104065 DOI: 10.1212/CPJ.0000000000000230 |
0.036 |
|
| 2008 |
Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 179: 787-93. PMID 18838454 DOI: 10.1503/Cmaj.070803 |
0.036 |
|
| 1994 |
Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 21: 9-14. PMID 8180914 DOI: 10.1017/S0317167100048691 |
0.036 |
|
| 2017 |
Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study. Neurology. PMID 29117961 DOI: 10.1212/WNL.0000000000004716 |
0.036 |
|
| 2003 |
Kingstone A, Klein R, Morein-Zamir S, Hunt A, Fisk J, Maxner C. Orienting attention in aging and Parkinson's disease: distinguishing modes of control. Journal of Clinical and Experimental Neuropsychology. 24: 951-67. PMID 12647771 DOI: 10.1076/Jcen.24.7.951.8387 |
0.035 |
|
| 2013 |
Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, Koch M, Makhani N, Morrow S, Fisk J, Dykeman J, Jetté N, Pringsheim T, Marrie RA. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 40: 195-210. PMID 23363936 DOI: 10.1159/000342779 |
0.035 |
|
| 2016 |
Marrie RA, Patten SB, Tremlett H, Wolfson C, Warren S, Svenson LW, Jette N, Fisk J. Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study. Neurology. PMID 26962066 DOI: 10.1212/Wnl.0000000000002481 |
0.035 |
|
| 2013 |
Marrie RA, Fisk JD, Stadnyk KJ, Yu BN, Tremlett H, Wolfson C, Warren S, Bhan V. The incidence and prevalence of multiple sclerosis in nova scotia, Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 824-31. PMID 24257224 |
0.035 |
|
| 2019 |
McKay KA, Manouchehrinia A, Berrigan L, Fisk JD, Olsson T, Hillert J. Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis. Jama Neurology. PMID 31206130 DOI: 10.1001/Jamaneurol.2019.1546 |
0.035 |
|
| 2016 |
Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, Fiest KM, McKay KA, Marrie RA. Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity. Neurology. PMID 26962068 DOI: 10.1212/Wnl.0000000000002564 |
0.034 |
|
| 2021 |
Ng HS, Zhu F, Kingwell E, Zhao Y, Yao S, Ekuma O, Svenson LW, Evans C, Fisk JD, Marrie RA, Tremlett H. Disease-modifying drugs for multiple sclerosis and subsequent health service use. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211063403. PMID 34949130 DOI: 10.1177/13524585211063403 |
0.034 |
|
| 2018 |
Orr J, Bernstein CN, Graff LA, Patten SB, Bolton JM, Sareen J, Marriott JJ, Fisk JD, Marrie RA. Factors associated with perceived need for mental health care in multiple sclerosis. Multiple Sclerosis and Related Disorders. 25: 179-185. PMID 30096684 DOI: 10.1016/j.msard.2018.07.043 |
0.034 |
|
| 2023 |
Yusuf FLA, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H. Gastrointestinal conditions in the multiple sclerosis prodrome. Annals of Clinical and Translational Neurology. PMID 38115680 DOI: 10.1002/acn3.51945 |
0.034 |
|
| 2010 |
Doward LC, Meads DM, Fisk J, Twiss J, Hagell P, Oprandi NC, Grand'Maison F, Bhan V, Arbizu T, Kohlmann T, Brassat D, Eckert BJ, McKenna SP. International development of the Unidimensional Fatigue Impact Scale (U-FIS). Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 463-8. PMID 20230543 DOI: 10.1111/j.1524-4733.2010.00706.x |
0.034 |
|
| 1982 |
Fisk JD, Goodale MA, Burkhart G, Barnett HJ. Progressive supranuclear palsy: the relationship between ocular motor dysfunction and psychological test performance. Neurology. 32: 698-705. PMID 7201107 DOI: 10.1212/Wnl.32.7.698 |
0.033 |
|
| 2006 |
Fisk JD, O'Reilly JP, Shaw AM. Reply to "comment on 'interfacial ph of an isolated silica-water interface'" Journal of Physical Chemistry B. 110: 15039-15040. DOI: 10.1021/jp056221e |
0.033 |
|
| 2023 |
Marrie RA, Lix LM, Bolton JM, Fisk JD, Fitzgerald KC, Graff LA, Hitchon CA, Kowalec K, Marriott JJ, Patten SB, Salter A, Bernstein CN. Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosis. Journal of Psychosomatic Research. 172: 111415. PMID 37331268 DOI: 10.1016/j.jpsychores.2023.111415 |
0.033 |
|
| 1991 |
Cormier P, Margison JA, Fisk JD. Contribution of perceptual and lexical-semantic errors to the naming impairments in Alzheimer's disease. Perceptual and Motor Skills. 73: 175-83. PMID 1945683 DOI: 10.2466/pms.1991.73.1.175 |
0.032 |
|
| 2012 |
Hanly JG, Su L, Omisade A, Farewell VT, Fisk JD. Screening for cognitive impairment in systemic lupus erythematosus. The Journal of Rheumatology. 39: 1371-7. PMID 22660804 DOI: 10.3899/jrheum.111504 |
0.032 |
|
| 2012 |
Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1310-9. PMID 22328682 DOI: 10.1177/1352458512437814 |
0.032 |
|
| 2000 |
Larrea FA, Fisk JD, Graham JE, Stadnyk K. Prevalence of cognitive impairment and dementia as defined by neuropsychological test performance. Neuroepidemiology. 19: 121-9. PMID 10705230 DOI: 10.1159/000026247 |
0.032 |
|
| 2015 |
Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB. Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology. PMID 26519542 DOI: 10.1212/WNL.0000000000002174 |
0.032 |
|
| 2012 |
Ploughman M, Austin MW, Murdoch M, Kearney A, Fisk JD, Godwin M, Stefanelli M. Factors influencing healthy aging with multiple sclerosis: a qualitative study. Disability and Rehabilitation. 34: 26-33. PMID 21902450 DOI: 10.3109/09638288.2011.585212 |
0.031 |
|
| 2022 |
Marrie RA, Fisk JD, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Marriott JJ, Bernstein CN. Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis. Frontiers in Neurology. 13: 874724. PMID 35493810 DOI: 10.3389/fneur.2022.874724 |
0.031 |
|
| 2020 |
Geddes MR, O'Connell ME, Fisk JD, Gauthier S, Camicioli R, Ismail Z. Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12111. PMID 32999916 DOI: 10.1002/dad2.12111 |
0.031 |
|
| 1992 |
Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. The Journal of Rheumatology. 19: 562-7. PMID 1593578 |
0.031 |
|
| 2020 |
Smith EE, Couillard P, Fisk JD, Ismail Z, Montero-Odasso M, Robillard JM, Vedel I, Sivananthan S, Gauthier S. Pandemic Dementia Scarce Resource Allocation. Canadian Geriatrics Journal : Cgj. 23: 216-218. PMID 32904792 DOI: 10.5770/Cgj.23.457 |
0.031 |
|
| 2018 |
McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. PMID 29523642 DOI: 10.1212/WNL.0000000000005302 |
0.031 |
|
| 2016 |
Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, McKay KA, Berrigan LI, Marrie RA. Fatigue and Comorbidities in Multiple Sclerosis. International Journal of Ms Care. 18: 96-104. PMID 27134583 DOI: 10.7224/1537-2073.2015-070 |
0.031 |
|
| 2018 |
Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, Leung S, Fiest KM, McKay KA, Fisk JD. Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis. International Journal of Ms Care. 20: 76-84. PMID 29670493 DOI: 10.7224/1537-2073.2016-110 |
0.031 |
|
| 2020 |
Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Marriott JJ, Bernstein CN. Effect of mood and anxiety disorders on health care utilization in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520963880. PMID 33045925 DOI: 10.1177/1352458520963880 |
0.031 |
|
| 2022 |
Hanly JG, Legge A, Kamintsky L, Friedman A, Hashmi JA, Beyea SD, Fisk J, Omisade A, Calkin C, Bardouille T, Bowen C, Matheson K, Fritzler MJ. Role of autoantibodies and blood-brain barrier leakage in cognitive impairment in systemic lupus erythematosus. Lupus Science & Medicine. 9. PMID 35705307 DOI: 10.1136/lupus-2022-000668 |
0.031 |
|
| 2008 |
Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion. 48: 2069-76. PMID 18631165 DOI: 10.1111/j.1537-2995.2008.01815.x |
0.03 |
|
| 1998 |
FisK JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ. Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 25: 230-5. PMID 9706725 |
0.03 |
|
| 2007 |
Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Neurology. 69: 1498-507. PMID 17699802 DOI: 10.1212/01.wnl.0000271884.11129.f3 |
0.03 |
|
| 2023 |
Enns MW, Bernstein CN, Graff L, Lix LM, Hitchon CA, Fisk JD, Dufault B, Marrie RA. A longitudinal study of distress symptoms and work impairment in immune-mediated inflammatory diseases. Journal of Psychosomatic Research. 174: 111473. PMID 37660681 DOI: 10.1016/j.jpsychores.2023.111473 |
0.029 |
|
| 2018 |
Marrie RA, Graff L, Walker JR, Fisk JD, Patten SB, Hitchon CA, Lix LM, Bolton J, Sareen J, Katz A, Berrigan LI, Marriott JJ, Singer A, El-Gabalawy R, Peschken CA, et al. Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study. Jmir Research Protocols. 7: e15. PMID 29343461 DOI: 10.2196/Resprot.8794 |
0.029 |
|
| 2020 |
Bernstein CN, Hitchon CA, Walld R, Bolton JM, Lix LM, El-Gabalawy R, Sareen J, Singer A, Katz A, Marriott J, Fisk JD, Patten SB, Marrie RA. The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study. Inflammatory Bowel Diseases. PMID 33274369 DOI: 10.1093/ibd/izaa310 |
0.029 |
|
| 2017 |
Mayo CD, Mazerolle EL, Ritchie L, Fisk JD, Gawryluk JR. Longitudinal changes in microstructural white matter metrics in Alzheimer's disease. Neuroimage. Clinical. 13: 330-338. PMID 28066707 DOI: 10.1016/J.Nicl.2016.12.012 |
0.029 |
|
| 2005 |
Klages JD, Fisk JD, Rockwood K. APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 20: 292-7. PMID 16166776 DOI: 10.1159/000088317 |
0.028 |
|
| 1999 |
Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis and Rheumatism. 42: 728-34. PMID 10211887 DOI: 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O |
0.028 |
|
| 2008 |
Brenner SR, Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS. How effective are disease-modifying drugs in delaying progression in relapsing-onset ms? Neurology. 71: 615; author reply 61. PMID 18711118 DOI: 10.1212/01.wnl.0000324708.37575.5c |
0.028 |
|
| 2020 |
Marrie RA, Patel R, Bernstein CN, Bolton JM, Graff LA, Marriott JJ, Hitchon CA, Figley CR, Kornelsen J, Fisk JD. Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520961534. PMID 32976067 DOI: 10.1177/1352458520961534 |
0.028 |
|
| 2016 |
Marrie RA, Patten SB, Greenfield J, Svenson LW, Jette N, Tremlett H, Wolfson C, Warren S, Profetto-McGrath J, Fisk JD, Blanchard J, Caetano P, Elliott L, Yu BN, et al. Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis. Brain and Behavior. 6: e00493. PMID 27688933 DOI: 10.1002/Brb3.493 |
0.028 |
|
| 2006 |
Asp E, Cloutier F, Fay S, Cook C, Robertson ML, Fisk J, Dei DW, Rockwood K. Verbal repetition in patients with Alzheimer's disease who receive donepezil. International Journal of Geriatric Psychiatry. 21: 426-31. PMID 16676290 DOI: 10.1002/gps.1486 |
0.028 |
|
| 2015 |
Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, McKay KA, Berrigan L, Marrie RA. Comorbidity is associated with pain-related activity limitations in multiple sclerosis. Multiple Sclerosis and Related Disorders. 4: 470-6. PMID 26346797 DOI: 10.1016/J.Msard.2015.07.014 |
0.027 |
|
| 2010 |
Hanly JG, Omisade A, Su L, Farewell V, Fisk JD. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. Arthritis and Rheumatism. 62: 1478-86. PMID 20155829 DOI: 10.1002/art.27404 |
0.027 |
|
| 2005 |
Passmore MJ, Ingles JL, Fisk JD, Darvesh S. Disconnection of language and memory in semantic dementia: a comparative and theoretical analysis. Current Alzheimer Research. 2: 435-48. PMID 16248849 DOI: 10.2174/156720505774330519 |
0.027 |
|
| 2019 |
Marrie RA, Walker JR, Graff LA, Patten SB, Bolton JM, Marriott JJ, Fisk JD, Hitchon C, Peschken C, Bernstein CN. Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis. Patient Education and Counseling. PMID 30982700 DOI: 10.1016/j.pec.2019.04.007 |
0.027 |
|
| 2019 |
Hamodat H, Fisk JD, Darvesh S. Cholinergic Neurons in Nucleus Subputaminalis in Primary Progressive Aphasia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-10. PMID 30819267 DOI: 10.1017/cjn.2019.6 |
0.027 |
|
| 2017 |
Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. Journal of Psychosomatic Research. 101: 17-23. PMID 28867419 DOI: 10.1016/J.Jpsychores.2017.07.015 |
0.027 |
|
| 1994 |
Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, Murray TJ. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain. 58: 89-93. PMID 7970843 |
0.026 |
|
| 2003 |
Klages JD, Fisk JD, Rockwood K. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging. Dementia and Geriatric Cognitive Disorders. 15: 1-5. PMID 12457072 DOI: 10.1159/000066670 |
0.026 |
|
| 2021 |
Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, Marriott JJ, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease. Plos One. 16: e0249809. PMID 34351924 DOI: 10.1371/journal.pone.0249809 |
0.026 |
|
| 2002 |
Klages J, Fisk JD. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging. Brain and Cognition. 49: 201-4. PMID 15259389 |
0.026 |
|
| 2023 |
Chertcoff AS, Yusuf F, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H. Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis. Neurology. PMID 37748884 DOI: 10.1212/WNL.0000000000207843 |
0.026 |
|
| 1997 |
Hanly JG, Cassell K, Fisk JD. Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis and Rheumatism. 40: 1542-3. PMID 9259438 DOI: 10.1002/ART.1780400825 |
0.026 |
|
| 2008 |
Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 179: 1019-26. PMID 18981443 DOI: 10.1503/Cmaj.081103 |
0.025 |
|
| 2023 |
Joyees J, Marrie RA, Bernstein CN, Bolton JM, Fisk JD, Graff LA, Hitchon C, Patten SB, Kowalec K. Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis. Frontiers in Psychiatry. 14: 1260420. PMID 38076706 DOI: 10.3389/fpsyt.2023.1260420 |
0.025 |
|
| 1994 |
Hanly JG, Fisk JD, Sherwood G, Eastwood B. Clinical course of cognitive dysfunction in systemic lupus erythematosus. The Journal of Rheumatology. 21: 1825-31. PMID 7837145 |
0.025 |
|
| 2022 |
Marrie RA, Fisk JD, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Marriott JJ, Bernstein CN. Prescription opioid use in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36028309 DOI: 10.1136/jnnp-2022-329508 |
0.025 |
|
| 2006 |
Hanly JG, Robichaud J, Fisk JD. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. The Journal of Rheumatology. 33: 1553-8. PMID 16881112 |
0.024 |
|
| 2018 |
Zhang T, Tremlett H, Zhu F, Kingwell E, Fisk JD, Bhan V, Campbell T, Stadnyk K, Carruthers R, Wolfson C, Warren S, Marrie RA. Effects of physical comorbidities on disability progression in multiple sclerosis. Neurology. PMID 29298855 DOI: 10.1212/WNL.0000000000004885 |
0.024 |
|
| 2017 |
Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data. Bmc Research Notes. 10: 619. PMID 29178935 DOI: 10.1186/S13104-017-2958-1 |
0.024 |
|
| 2007 |
Ingles JL, Boulton DC, Fisk JD, Rockwood K. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis. Stroke; a Journal of Cerebral Circulation. 38: 1148-53. PMID 17322075 DOI: 10.1161/01.Str.0000259716.04739.60 |
0.024 |
|
| 1985 |
Johnson DM, Hopkins RJ, Hanafee WN, Fisk JD. The unprotected parasphenoidal carotid artery studied by high-resolution computed tomography. Radiology. 155: 137-41. PMID 3975391 DOI: 10.1148/radiology.155.1.3975391 |
0.024 |
|
| 2005 |
Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. The Journal of Rheumatology. 32: 1459-6. PMID 16078320 |
0.023 |
|
| 2020 |
Yusuf F, Wijnands JM, Kingwell E, Zhu F, Evans C, Fisk JD, Zhao Y, Sutherland JM, Patrick DM, Marrie RA, Tremlett H. Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520908163. PMID 32250183 DOI: 10.1177/1352458520908163 |
0.023 |
|
| 2021 |
Kamintsky L, Beyea SD, Fisk JD, Hashmi JA, Omisade A, Calkin C, Bardouille T, Bowen C, Quraan M, Mitnitski A, Matheson K, Friedman A, Hanly JG. Response to: 'Correspondence on 'Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment'' by Pamuk and Hasni. Annals of the Rheumatic Diseases. PMID 33622691 DOI: 10.1136/annrheumdis-2021-220057 |
0.022 |
|
| 2002 |
Ingles JL, Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke; a Journal of Cerebral Circulation. 33: 1999-2002. PMID 12154252 DOI: 10.1161/01.Str.0000024433.36590.1B |
0.022 |
|
| 2003 |
Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 61: 1179-84. PMID 14610117 |
0.022 |
|
| 1999 |
Doble SE, Fisk JD, Lewis N, Rockwood K. Test-retest reliability of the assessment of motor and process skills in elderly adults Occupational Therapy Journal of Research. 19: 203-215. DOI: 10.1177/153944929901900303 |
0.022 |
|
| 2016 |
Marrie RA, Patten S, Tremlett H, Svenson LW, Wolfson C, Yu BN, Elliott L, Profetto-McGrath J, Warren S, Leung S, Jette N, Bhan V, Fisk JD. Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends. Multiple Sclerosis and Related Disorders. 8: 86-92. PMID 27456880 DOI: 10.1016/J.Msard.2016.05.009 |
0.022 |
|
| 2015 |
McKay KA, Tremlett H, Fisk JD, Patten SB, Fiest K, Berrigan L, Marrie RA. Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26245214 DOI: 10.1177/1352458515599073 |
0.022 |
|
| 2020 |
Wallace LMK, Theou O, Darvesh S, Bennett DA, Buchman AS, Andrew MK, Kirkland S, Fisk JD, Rockwood K. Neuropathological burden and the degree of frailty in relation to global cognition and dementia. Neurology. PMID 32989103 DOI: 10.1212/WNL.0000000000010944 |
0.022 |
|
| 2021 |
Stewart SA, Pimer L, Fisk JD, Rusak B, Leslie RA, Eskes G, Schoffer K, McKelvey JR, Rolheiser T, Khan MN, Robertson H, Good KP. Olfactory Function and Diffusion Tensor Imaging as Markers of Mild Cognitive Impairment in Early Stages of Parkinson's Disease. Clinical Eeg and Neuroscience. 15500594211058263. PMID 34841903 DOI: 10.1177/15500594211058263 |
0.022 |
|
| 1999 |
Liang MH, Corzillius M, Bae SC, Lew RA, Fortin PR, Gordon C, Isenberg D, Alarcón GS, Straaton KV, Denburg J, Denburg S, Esdaile JM, Glanz BI, Karlson EW, Khoshbin S, ... ... Fisk JD, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes Arthritis and Rheumatism. 42: 599-608. PMID 10211873 DOI: 10.1002/1529-0131(199904)42:4<599::Aid-Anr2>3.0.Co;2-F |
0.022 |
|
| 2022 |
Bernstein CN, Fisk JD, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Graff LA, Katz A, Witges K, Marriott JJ, Marrie RA. Use of Benzodiazepines and Z-Drugs in Inflammatory Bowel Disease. The American Journal of Gastroenterology. PMID 36288107 DOI: 10.14309/ajg.0000000000001955 |
0.022 |
|
| 2022 |
Hanly JG, Robertson JW, Legge A, Kamintsky L, Aristi G, Friedman A, Beyea SD, Fisk JD, Omisade A, Calkin C, Bardouille T, Bowen C, Matheson K, Hashmi JA. Resting state functional connectivity in SLE patients and association with cognitive impairment and blood-brain barrier permeability. Rheumatology (Oxford, England). PMID 35699463 DOI: 10.1093/rheumatology/keac343 |
0.021 |
|
| 2022 |
Yusuf FLA, Wijnands JMA, Karim ME, Kingwell E, Zhu F, Evans C, Fisk JD, Zhao Y, Marrie RA, Tremlett H. Sex and age differences in the Multiple Sclerosis prodrome. Frontiers in Neurology. 13: 1017492. PMID 36408518 DOI: 10.3389/fneur.2022.1017492 |
0.021 |
|
| 2018 |
Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA. The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 29668911 DOI: 10.1093/Ibd/Izy068 |
0.021 |
|
| 2023 |
Almweisheer S, Bernstein CN, Graff LA, Patten SB, Bolton J, Fisk JD, Hitchon CA, Marriott JJ, Marrie RA. Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study. Bmj Open. 13: e073782. PMID 37295825 DOI: 10.1136/bmjopen-2023-073782 |
0.021 |
|
| 1981 |
Fisk JD, Shulman HM, Greening RR, McDonald GB, Sale GE, Thomas ED. Gastrointestinal radiographic features of human graft-vs.-host disease. Ajr. American Journal of Roentgenology. 136: 329-36. PMID 6781255 DOI: 10.2214/ajr.136.2.329 |
0.02 |
|
| 1996 |
Ritvo PG, Fisk JD, Archibald CJ, Murray TJ, Field C. Psychosocial and neurological predictors of mental health in multiple sclerosis patients. Journal of Clinical Epidemiology. 49: 467-72. PMID 8621999 |
0.02 |
|
| 2023 |
Bernstein CN, Dolovich C, Prichodko M, Fisk JD, Graff LA, Patten SB, Bolton J, Hitchon C, Marrie RA. Perceived Need for Mental Health Care in a Cohort of Persons With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. PMID 37725433 DOI: 10.1097/MCG.0000000000001892 |
0.02 |
|
| 2020 |
Marrie RA, Whitehouse C, Fisk J. Author response: Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders. Neurology. 93: 1081-1082. PMID 31819000 DOI: 10.1212/WNL.0000000000008634 |
0.019 |
|
| 2023 |
Jain D, Bernstein CN, Graff LA, Patten SB, Bolton JM, Fisk JD, Hitchon C, Marriott JJ, Marrie RA. Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9: 20552173231188469. PMID 37483527 DOI: 10.1177/20552173231188469 |
0.019 |
|
| 2023 |
Marrie RA, Fisk JD, Dolovich C, Lix LM, Graff LA, Patten SB, Bernstein CN. Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 36917218 DOI: 10.1093/ibd/izad038 |
0.019 |
|
| 2019 |
Reinhorn IM, Bernstein CN, Graff LA, Patten SB, Sareen J, Fisk JD, Bolton JM, Hitchon C, Marrie RA. Social phobia in immune-mediated inflammatory diseases. Journal of Psychosomatic Research. 128: 109890. PMID 31816595 DOI: 10.1016/j.jpsychores.2019.109890 |
0.018 |
|
| 2021 |
Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN. The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time. Inflammatory Bowel Diseases. PMID 33393632 DOI: 10.1093/ibd/izaa349 |
0.018 |
|
| 2019 |
Whitehouse CE, Fisk JD, Bernstein CN, Berrigan LI, Bolton JM, Graff LA, Hitchon CA, Marriott JJ, Peschken CA, Sareen J, Walker JR, Stewart SH, Marrie RA. Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders. Neurology. PMID 30635487 DOI: 10.1212/Wnl.0000000000006854 |
0.018 |
|
| 2011 |
Andrew MK, Fisk JD, Rockwood K. Social vulnerability and prefrontal cortical function in elderly people: a report from the Canadian Study of Health and Aging. International Psychogeriatrics / Ipa. 23: 450-8. PMID 20699047 DOI: 10.1017/S1041610210001195 |
0.017 |
|
| 2000 |
Fisk JD, Boyle JD. Electrolytic toxic metal removal from effluents using reticulated vitreous carbon Transactions of the Institute of Metal Finishing. 78: 113-119. |
0.017 |
|
| 2000 |
McMullen PA, Fisk JD, Phillips SJ, Maloney WJ. Apperceptive agnosia and face recognition Neurocase. 6: 403-414. |
0.017 |
|
| 2021 |
Wan A, Bernstein CN, Graff LA, Patten SB, Sareen J, Fisk JD, Bolton JM, Hitchon C, Marriott JJ, Marrie RA. Childhood maltreatment and psychiatric comorbidity in immune-mediated inflammatory disorders. Psychosomatic Medicine. PMID 34654023 DOI: 10.1097/PSY.0000000000001025 |
0.017 |
|
| 2021 |
MacDonald TM, Fisk JD, Bernstein CN, El-Gabalawy R, Hitchon CA, Kornelsen J, Patten SB, Tisseverasinghe A, Marrie RA. The association between childhood maltreatment and pain catastrophizing in individuals with immune-mediated inflammatory diseases. Journal of Psychosomatic Research. 110479. PMID 33814193 DOI: 10.1016/j.jpsychores.2021.110479 |
0.016 |
|
| 2021 |
Marrie RA, Patel R, Figley CR, Kornelsen J, Bolton JM, Graff LA, Mazerolle EL, Helmick C, O'Grady C, Uddin MN, Marriott JJ, Bernstein CN, Fisk JD. Higher Framingham Risk Scores are associated with greater loss of brain volume over time in multiple sclerosis. Multiple Sclerosis and Related Disorders. 54: 103088. PMID 34186319 DOI: 10.1016/j.msard.2021.103088 |
0.016 |
|
| 2009 |
Poder K, Ghatavi K, Fisk JD, Campbell TL, Kisely S, Sarty I, Stadnyk K, Bhan V. Social anxiety in a multiple sclerosis clinic population. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 393-8. PMID 19028833 DOI: 10.1177/1352458508099143 |
0.016 |
|
| 2011 |
Hanly JG, Fisk JD. Diagnosis of cognitive impairment in adult and pediatric SLE. Nature Reviews. Rheumatology. 7: 564-5. PMID 21862982 DOI: 10.1038/nrrheum.2011.127 |
0.016 |
|
| 2023 |
Bernstein CN, Fisk JD, Dolovich C, Hitchon CA, Graff LA, El-Gabalawy R, Lix LM, Bolton JM, Patten SB, Marrie RA. Understanding predictors of fatigue over time in persons with IBD: The importance of depressive and anxiety symptoms. The American Journal of Gastroenterology. PMID 38088416 DOI: 10.14309/ajg.0000000000002630 |
0.015 |
|
| 2020 |
Jain A, Marrie RA, Shafer LA, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Fisk JD, Bernstein CN. Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review. Crohn's & Colitis 360. 2: otz053. PMID 32003760 DOI: 10.1093/crocol/otz053 |
0.015 |
|
| 2002 |
Rockwood K, Brown M, Merry H, Sketris I, Fisk J. Societal costs of vascular cognitive impairment in older adults. Stroke. 33: 1605-9. PMID 12052999 DOI: 10.1161/01.str.0000017878.85274.44 |
0.015 |
|
| 2018 |
Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, Graff LA, Patten SB, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Marrie RA. Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 29986021 DOI: 10.1093/Ibd/Izy235 |
0.014 |
|
| 2020 |
Hitchon CA, Walld R, Peschken CA, Bernstein CN, Bolton JM, El-Gabalawy R, Fisk JD, Katz A, Lix LM, Marriott J, Patten SB, Sareen J, Singer A, Marrie RA. The Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population-Based Study. Arthritis Care & Research. PMID 32702203 DOI: 10.1002/Acr.24386 |
0.013 |
|
| 2018 |
Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease. General Hospital Psychiatry. 51: 71-78. PMID 29353127 DOI: 10.1016/J.Genhosppsych.2018.01.003 |
0.012 |
|
| 2020 |
Kamintsky L, Beyea SD, Fisk JD, Hashmi JA, Omisade A, Calkin C, Bardouille T, Bowen C, Quraan M, Mitnitski A, Matheson K, Friedman A, Hanly JG. Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment. Annals of the Rheumatic Diseases. PMID 33004325 DOI: 10.1136/annrheumdis-2020-218004 |
0.012 |
|
| 2021 |
Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, Marriott JJ, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study. Cmaj Open. 9: E510-E521. PMID 33990365 DOI: 10.9778/cmajo.20200105 |
0.011 |
|
| 2019 |
Hitchon CA, Zhang L, Peschken CA, Lix LM, Graff LA, Fisk JD, Patten SB, Bolton J, Sareen J, El-Gabalawy R, Marriott J, Bernstein CN, Marrie R. The validity and reliability of screening measures for depression and anxiety disorders in rheumatoid arthritis. Arthritis Care & Research. PMID 31199570 DOI: 10.1002/acr.24011 |
0.011 |
|
| 2018 |
Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. General Hospital Psychiatry. 53: 65-72. PMID 29929117 DOI: 10.1016/J.Genhosppsych.2018.06.001 |
0.01 |
|
| 2022 |
Calocer F, Ng HS, Zhu F, Zhao Y, Dejardin O, Leray E, Defer G, Evans C, Fisk JD, Marrie RA, Tremlett H. Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221129963. PMID 36281835 DOI: 10.1177/13524585221129963 |
0.01 |
|
| 2019 |
Lewis K, Marrie RA, Bernstein CN, Graff LA, Patten SB, Sareen J, Fisk JD, Bolton JM. The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 30888037 DOI: 10.1093/Ibd/Izz045 |
0.01 |
|
| 2018 |
Litster B, Bernstein CN, Graff LA, Walker JR, Fisk JD, Patten SB, Bolton JM, Sareen J, El-Gabalawy R, Marrie RA. Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 29522100 DOI: 10.1093/Ibd/Izy032 |
0.01 |
|
| 2018 |
Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis Care & Research. PMID 29438604 DOI: 10.1002/Acr.23539 |
0.01 |
|
| 2014 |
Hanly JG, Omisade A, Fisk JD. Treatment of neuropsychiatric lupus Rheumatology: Sixth Edition. 2: 1107-1111. DOI: 10.1016/B978-0-323-09138-1.00135-2 |
0.01 |
|
| 2012 |
Hanly JG, Omisade A, Fisk JD. Psychopathology, Neurodiagnostic Testing, and Imaging Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition. 382-392. DOI: 10.1016/B978-1-4377-1893-5.00030-3 |
0.01 |
|
| 2007 |
Fisk JD. Ethical considerations for the conduct of antidementia trials in Canada. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 34: S32-6. PMID 17469679 |
0.01 |
|
| 2005 |
Meads D, Hampson N, Fisk J, McKenna S, Doward L, Mayo K. PMC17 RASCH ANALYSIS OF THE FATIGUE IMPACT SCALE Value in Health. 8: A70. DOI: 10.1016/S1098-3015(10)67354-8 |
0.01 |
|
| 1981 |
Williams BD, Fisk JD. Sonographic diagnosis of giant urachal cyst in the adult. Ajr. American Journal of Roentgenology. 136: 417-8. PMID 6781271 DOI: 10.2214/ajr.136.2.417 |
0.01 |
|
| Hide low-probability matches. |